KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Invested Capital: 2009-2025

Historic Invested Capital for Teva Pharmaceutical Industries (TEVA) over the last 13 years, with Sep 2025 value amounting to $7.3 billion.

  • Teva Pharmaceutical Industries' Invested Capital fell 18.80% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year decrease of 18.80%. This contributed to the annual value of $7.2 billion for FY2024, which is 26.91% down from last year.
  • According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Invested Capital is $7.3 billion, which was down 0.27% from $7.3 billion recorded in Q2 2025.
  • Teva Pharmaceutical Industries' 5-year Invested Capital high stood at $14.8 billion for Q2 2021, and its period low was $6.7 billion during Q1 2025.
  • In the last 3 years, Teva Pharmaceutical Industries' Invested Capital had a median value of $8.9 billion in 2023 and averaged $8.6 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Invested Capital grew by 11.51% in 2021 and then crashed by 36.90% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Invested Capital (Quarterly) stood at $12.7 billion in 2021, then declined by 15.49% to $10.7 billion in 2022, then dropped by 8.49% to $9.8 billion in 2023, then fell by 26.91% to $7.2 billion in 2024, then fell by 18.80% to $7.3 billion in 2025.
  • Its last three reported values are $7.3 billion in Q3 2025, $7.3 billion for Q2 2025, and $6.7 billion during Q1 2025.